Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Hematologic Neoplasms × Lisaftoclax × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

venetoclax 1 ruxolitinib 1 isatuximab 1 Tissue Plasminogen Activator 1 Therapeutics 1 Stem Cell Transplantation 1 Psychiatric Rehabilitation 1 Oxymorphone 1 Oxycodone 1 Morphine 1 Lisaftoclax 1 Levorphanol 1 Kidney Transplantation 1 Hyperthermia, Induced 1 Hydromorphone 1 Hydrocodone 1 Diathermy 1 Counseling 1 Cell- and Tissue-Based Therapy 1 CF regimen 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03537482 2024-08-19

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Ascentage Pharma Group Inc.

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡